Cancer is a condition where a cell reproduces uncontrollably. Cancerous cells can invade and destroys healthy tissues and organs. A question which is always raised any time cancer is discussed is how to prevent and detect earlier. It is a unique and unconventional life threatening disease. There are all most 200 different types of Cancer, each requires specific approaches for treatment. Cancer Research is a huge arena, understanding the causes, to whom and why it happens and how to get rid of it. Cancer always is a complex question, and there are no simple answers so far. It is important to discuss and investigate cancer as much as possible. It can be solved only by the collective approach.

Cancer Epidemiology, Research and Market

The global cancer diagnostics market was valued at USD 101.0 billion in 2013 and is expected to grow at a CAGR of 7.6% from 2014 to 2020, to reach an estimated value of USD 168.6 billion in 2020. The global cancer biomarkers market is expected to reach USD 15,973.8 Million by 2020, at a CAGR of 11.6% from 2015 to 2020. In 2010, the global cancer market was valued at $54 billion, with forecasted Compound Annual Growth Rate (CAGR) growth to $81 billion by 2016. The seven major cancer markets (US, France, Germany, Italy, Spain, United Kingdom and Japan) represented ~79% of the 2010 global cancer market ($43 billion). The US dominated 2010 sales with a market share of 38.5% and the leading ten companies of the global cancer market represented 87.1% ($47 billion) of the total market.

With an aim of providing a global platform to the researchers across the globe, Conferenceseries Ltd is organizing Cancer Conferences every year on wide range of cancer topics.

Objective: To get an insight about the on-going and future prospect of cancer research worldwide.

Accreditation: Majority of this cancer conference will be providing CME and CPD credits.